Clinical Trials Logo

Amyloidosis, Hereditary clinical trials

View clinical trials related to Amyloidosis, Hereditary.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT03400098 Approved for marketing - Clinical trials for Amyloidosis, Hereditary

ATTR Expanded Access Program (EAP) by Ionis

Start date: n/a
Phase:
Study type: Expanded Access

The purpose of this program is to provide expanded access to Inotersen for up to 100 Patients with Hereditary Transthyretin Amyloidosis (hTTR).

NCT ID: NCT02939820 Approved for marketing - Clinical trials for Amyloidosis, Hereditary

Expanded Access Protocol of Patisiran for Patients With Hereditary ATTR Amyloidosis (hATTR)

Start date: n/a
Phase:
Study type: Expanded Access

The purpose of this study is to provide expanded access of patisiran to patients with hereditary transthyretin-mediated amyloidosis (hATTR).